The Cooper Companies, Inc

NASDAQ:COO USA Medical Instruments & Supplies
Market Cap
$14.06 Billion
Market Cap Rank
#1305 Global
#994 in USA
Share Price
$72.05
Change (1 day)
+1.42%
52-Week Range
$64.32 - $84.98
All Time High
$113.94
About

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and wome… Read more

The Cooper Companies, Inc (COO) - Net Assets

Latest net assets as of January 2026: $8.36 Billion USD

Based on the latest financial reports, The Cooper Companies, Inc (COO) has net assets worth $8.36 Billion USD as of January 2026.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($12.42 Billion) and total liabilities ($4.06 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $8.36 Billion
% of Total Assets 67.32%
Annual Growth Rate 9.69%
5-Year Change 18.68%
10-Year Change 205.15%
Growth Volatility 174.87

The Cooper Companies, Inc - Net Assets Trend (1985–2025)

This chart illustrates how The Cooper Companies, Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for The Cooper Companies, Inc (1985–2025)

The table below shows the annual net assets of The Cooper Companies, Inc from 1985 to 2025.

Year Net Assets Change
2025-10-31 $8.24 Billion +1.92%
2024-10-31 $8.08 Billion +7.05%
2023-10-31 $7.55 Billion +5.24%
2022-10-31 $7.17 Billion +3.35%
2021-10-31 $6.94 Billion +81.50%
2020-10-31 $3.82 Billion +5.41%
2019-10-31 $3.63 Billion +9.70%
2018-10-31 $3.31 Billion +4.16%
2017-10-31 $3.18 Billion +17.62%
2016-10-31 $2.70 Billion +0.98%
2015-10-31 $2.67 Billion +3.30%
2014-10-31 $2.59 Billion +6.81%
2013-10-31 $2.42 Billion +9.50%
2012-10-31 $2.21 Billion +14.23%
2011-10-31 $1.94 Billion +16.24%
2010-10-31 $1.67 Billion +8.21%
2009-10-31 $1.54 Billion +8.70%
2008-10-31 $1.42 Billion -0.46%
2007-10-31 $1.42 Billion +3.27%
2006-10-31 $1.38 Billion +8.27%
2005-10-31 $1.27 Billion +133.98%
2004-10-31 $544.16 Million +28.93%
2003-10-31 $422.05 Million +35.51%
2002-10-31 $311.44 Million +21.52%
2001-10-31 $256.28 Million +29.15%
2000-10-31 $198.44 Million +20.93%
1999-10-31 $164.10 Million +12.94%
1998-10-31 $145.30 Million +30.31%
1997-10-31 $111.50 Million +628.76%
1996-10-31 $15.30 Million +1000.00%
1995-10-31 $-1.70 Million +54.05%
1994-10-31 $-3.70 Million -840.00%
1993-10-31 $500.00K -98.92%
1992-10-31 $46.30 Million -35.43%
1991-10-31 $71.70 Million -16.14%
1990-10-31 $85.50 Million -15.93%
1989-10-31 $101.70 Million +112.76%
1988-10-31 $47.80 Million -81.43%
1987-10-31 $257.40 Million +16.47%
1986-10-31 $221.00 Million +8.28%
1985-10-31 $204.10 Million --

Equity Component Analysis

This analysis shows how different components contribute to The Cooper Companies, Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 6460.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (October 2025)

Component Amount Percentage
Retained Earnings $7.64 Billion 92.77%
Common Stock $21.80 Million 0.26%
Other Comprehensive Income $-406.50 Million -4.93%
Other Components $980.30 Million 11.90%
Total Equity $8.24 Billion 100.00%

The Cooper Companies, Inc Competitors by Market Cap

The table below lists competitors of The Cooper Companies, Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in The Cooper Companies, Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 8,083,400,000 to 8,238,900,000, a change of 155,500,000 (1.9%).
  • Net income of 374,900,000 contributed positively to equity growth.
  • Share repurchases of 290,100,000 reduced equity.
  • Other comprehensive income increased equity by 15,200,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $374.90 Million +4.55%
Share Repurchases $290.10 Million -3.52%
Other Comprehensive Income $15.20 Million +0.18%
Other Changes $55.50 Million +0.67%
Total Change $- 1.92%

Book Value vs Market Value Analysis

This analysis compares The Cooper Companies, Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.75x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 19.72x to 1.75x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1985-10-31 $3.65 $72.05 x
1986-10-31 $3.79 $72.05 x
1987-10-31 $3.99 $72.05 x
1988-10-31 $0.77 $72.05 x
1989-10-31 $1.64 $72.05 x
1990-10-31 $1.26 $72.05 x
1991-10-31 $1.04 $72.05 x
1992-10-31 $0.60 $72.05 x
1993-10-31 $0.01 $72.05 x
1994-10-31 $-0.04 $72.05 x
1995-10-31 $-0.02 $72.05 x
1996-10-31 $0.16 $72.05 x
1997-10-31 $1.08 $72.05 x
1998-10-31 $1.19 $72.05 x
1999-10-31 $1.43 $72.05 x
2000-10-31 $1.71 $72.05 x
2001-10-31 $2.10 $72.05 x
2002-10-31 $2.50 $72.05 x
2003-10-31 $3.17 $72.05 x
2004-10-31 $3.80 $72.05 x
2005-10-31 $7.08 $72.05 x
2006-10-31 $7.24 $72.05 x
2007-10-31 $8.16 $72.05 x
2008-10-31 $7.56 $72.05 x
2009-10-31 $8.47 $72.05 x
2010-10-31 $8.96 $72.05 x
2011-10-31 $10.03 $72.05 x
2012-10-31 $11.15 $72.05 x
2013-10-31 $12.10 $72.05 x
2014-10-31 $13.12 $72.05 x
2015-10-31 $13.55 $72.05 x
2016-10-31 $13.75 $72.05 x
2017-10-31 $16.01 $72.05 x
2018-10-31 $16.64 $72.05 x
2019-10-31 $18.12 $72.05 x
2020-10-31 $19.30 $72.05 x
2021-10-31 $34.81 $72.05 x
2022-10-31 $36.09 $72.05 x
2023-10-31 $37.91 $72.05 x
2024-10-31 $40.34 $72.05 x
2025-10-31 $41.19 $72.05 x

Capital Efficiency Dashboard

This dashboard shows how efficiently The Cooper Companies, Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 4.55%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 9.16%
  • • Asset Turnover: 0.33x
  • • Equity Multiplier: 1.50x
  • Recent ROE (4.55%) is above the historical average (-227.65%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1985 17.25% 10.63% 0.61x 2.67x $14.79 Million
1986 -17.51% -8.41% 0.54x 3.85x $-60.80 Million
1987 26.53% 10.88% 0.46x 5.28x $42.56 Million
1988 -317.36% -24.82% 0.54x 23.80x $-156.48 Million
1989 -16.03% -30.87% 0.18x 2.83x $-26.47 Million
1990 -1.99% -3.53% 0.22x 2.54x $-10.25 Million
1991 -34.59% -69.86% 0.19x 2.62x $-31.97 Million
1992 -53.78% -39.34% 0.36x 3.76x $-29.53 Million
1993 -9380.00% -50.59% 0.85x 219.00x $-46.95 Million
1994 0.00% -4.92% 1.01x 0.00x $-4.33 Million
1995 0.00% 0.10% 1.06x 0.00x $270.00K
1996 108.50% 15.22% 1.06x 6.73x $15.07 Million
1997 28.16% 22.19% 0.81x 1.57x $20.25 Million
1998 27.39% 27.04% 0.50x 2.04x $25.27 Million
1999 15.30% 15.18% 0.58x 1.74x $8.69 Million
2000 14.60% 14.68% 0.61x 1.63x $9.12 Million
2001 14.49% 15.83% 0.59x 1.55x $11.51 Million
2002 15.69% 15.50% 0.55x 1.83x $17.73 Million
2003 16.29% 16.70% 0.58x 1.67x $26.57 Million
2004 17.06% 18.94% 0.60x 1.49x $38.41 Million
2005 7.20% 11.37% 0.37x 1.71x $-35.60 Million
2006 4.80% 7.71% 0.37x 1.71x $-71.62 Million
2007 -0.77% -1.18% 0.37x 1.75x $-157.14 Million
2008 4.62% 6.16% 0.41x 1.83x $-76.23 Million
2009 6.53% 9.31% 0.42x 1.66x $-53.49 Million
2010 6.77% 9.74% 0.46x 1.51x $-53.87 Million
2011 9.05% 13.18% 0.51x 1.35x $-18.32 Million
2012 11.33% 17.18% 0.49x 1.34x $29.06 Million
2013 12.32% 18.65% 0.51x 1.30x $55.70 Million
2014 10.50% 15.71% 0.39x 1.73x $12.87 Million
2015 7.63% 11.33% 0.40x 1.67x $-63.23 Million
2016 10.16% 13.93% 0.44x 1.66x $4.34 Million
2017 11.74% 17.43% 0.44x 1.53x $55.33 Million
2018 4.23% 5.52% 0.41x 1.85x $-190.86 Million
2019 12.86% 17.59% 0.42x 1.73x $103.86 Million
2020 6.23% 9.81% 0.36x 1.76x $-144.06 Million
2021 42.42% 100.76% 0.30x 1.38x $2.25 Billion
2022 5.38% 11.66% 0.29x 1.60x $-331.65 Million
2023 3.90% 8.19% 0.31x 1.54x $-460.88 Million
2024 4.85% 10.07% 0.32x 1.52x $-416.04 Million
2025 4.55% 9.16% 0.33x 1.50x $-448.99 Million

Industry Comparison

This section compares The Cooper Companies, Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $2,683,526,542
  • Average return on equity (ROE) among peers: -32.48%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
The Cooper Companies, Inc (COO) $8.36 Billion 17.25% 0.49x $13.97 Billion
ANGELALIGN TECHNOLOGY INC (AGLFF) $480.24 Million 2.52% 0.41x $405.57 Million
Akoya Biosciences Inc (AKYA) $-30.16 Million 0.00% 0.00x $16.24 Million
Alcon AG (ALC) $19.68 Billion 1.70% 0.48x $37.82 Billion
Align Technology Inc (ALGN) $3.85 Billion 10.94% 0.61x $11.75 Billion
AngioDynamics Inc (ANGO) $355.71 Million 3.06% 0.15x $354.40 Million
Ansell Limited (ANSLF) $386.33 Million -0.45% 0.87x $2.58 Billion
AptarGroup Inc (ATR) $2.07 Billion 11.57% 1.03x $8.27 Billion
AtriCure Inc (ATRC) $72.60 Million -15.79% 0.54x $1.42 Billion
Avinger Inc (AVGR) $-35.69 Million 0.00% 0.00x $1.26 Million
Anteris Technologies Global Corp. Common Stock (AVR) $9.03 Million -338.35% 0.77x $156.14 Million